Search Results - Busque, Stephan
- Showing 1 - 20 results of 21
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
SARS-CoV-2 Neutralizing Monoclonal Antibodies for the Treatment of COVID-19 in Kidney Transplant Recipients by Wang, Aileen X., Busque, Stephan, Kuo, Jamie, Singh, Upinder, Röeltgen, Katharina, Pinsky, Benjamin A., Chertow, Glenn M., Scandling, John D., Lenihan, Colin R.
Published 2021Text -
15
Tolerance and Withdrawal of Immunosuppressive Drugs in Patients Given Kidney and Hematopoietic Cell Transplants by Scandling, John D., Busque, Stephan, Dejbakhsh-Jones, Sussan, Benike, Claudia, Sarwal, Minnie, Millan, Maria T., Shizuru, Judith A., Lowsky, Robert, Engleman, Edgar G., Strober., Samuel
Published 2012Text -
16
Trends in Cost Attributable to Kidney Transplantation Evaluation and Waiting List Management in the United States, 2012-2017 by Cheng, Xingxing S., Han, Jialin, Braggs-Gresham, Jennifer L., Held, Philip J., Busque, Stephan, Roberts, John P., Tan, Jane C., Scandling, John D., Chertow, Glenn M., Dor, Avi
Published 2022Text -
17
Efficacy and Safety of a Tofacitinib-based Immunosuppressive Regimen After Kidney Transplantation: Results From a Long-term Extension Trial by Busque, Stephan, Vincenti, Flavio G., Tedesco Silva, Helio, O’Connell, Philip J., Yoshida, Atsushi, Friedewald, John J., Steinberg, Steven M., Budde, Klemens, Broeders, Emine N., Kim, Yon Su, Hahn, Carolyn M., Li, Huihua, Chan, Gary
Published 2018Text -
18
Cellular and humoral immune response to SARS-CoV-2 vaccination and booster dose in immunosuppressed patients: An observational cohort study by Yang, Lu M., Costales, Cristina, Ramanathan, Muthukumar, Bulterys, Philip L., Murugesan, Kanagavel, Schroers-Martin, Joseph, Alizadeh, Ash A., Boyd, Scott D., Brown, Janice M., Nadeau, Kari C., Nadimpalli, Sruti S., Wang, Aileen X., Busque, Stephan, Pinsky, Benjamin A., Banaei, Niaz
Published 2022Text -
19
Mixed chimerism and acceptance of kidney transplants after immunosuppressive drug withdrawal by Busque, Stephan, Scandling, John D., Lowsky, Robert, Shizuru, Judith, Jensen, Kent, Waters, Jeffrey, Wu, Hsin-Hsu, Sheehan, Kevin, Shori, Asha, Choi, Okmi, Pham, Thomas, Fernandez Vina, Marcelo A., Hoppe, Richard, Tamaresis, John, Lavori, Philip, Engleman, Edgar G., Meyer, Everett, Strober, Samuel
Published 2020Text -
20
Safety, pharmacokinetics, and pharmacodynamic activity of obinutuzumab, a type 2 anti‐CD20 monoclonal antibody for the desensitization of candidates for renal transplant by Redfield, Robert R., Jordan, Stanley C., Busque, Stephan, Vincenti, Flavio, Woodle, E. Steve, Desai, Niraj, Reed, Elaine F., Tremblay, Simon, Zachary, Andrea A., Vo, Ashley A., Formica, Richard, Schindler, Thomas, Tran, Ha, Looney, Caroline, Jamois, Candice, Green, Cherie, Morimoto, Alyssa, Rajwanshi, Richa, Schroeder, Aaron, Cascino, Matthew D., Brunetta, Paul, Borie, Dominic
Published 2019Text